
RNAnalytics develops modular analysis components and an integrated software platform for characterizing Lipid Nanoparticles (LNPs). Their solution is aimed at developers of RNA and gene therapies who want to simplify, standardize, and secure complex laboratory processes without needing to purchase new equipment. The technology platform combines validated laboratory protocols for measuring critical quality parameters, reagents and reference materials for standardization, cloud-based software for automated evaluation, Part 11-compliant report generation, and data management, with scalable interfaces for integration into existing LIMS and production systems. RNAnalytics targets CROs, CDMOs, biopharma, industrial development, RNA startups, and academic labs, offering standardized methods, platform-based evaluation, AI-driven comparability, and low-threshold access to reproducible analytics.

RNAnalytics develops modular analysis components and an integrated software platform for characterizing Lipid Nanoparticles (LNPs). Their solution is aimed at developers of RNA and gene therapies who want to simplify, standardize, and secure complex laboratory processes without needing to purchase new equipment. The technology platform combines validated laboratory protocols for measuring critical quality parameters, reagents and reference materials for standardization, cloud-based software for automated evaluation, Part 11-compliant report generation, and data management, with scalable interfaces for integration into existing LIMS and production systems. RNAnalytics targets CROs, CDMOs, biopharma, industrial development, RNA startups, and academic labs, offering standardized methods, platform-based evaluation, AI-driven comparability, and low-threshold access to reproducible analytics.